These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 22103968)
1. Treatment of refractory atopic blepharoconjunctivitis with topical tacrolimus 0.03% dermatologic ointment. Sakarya Y; Sakarya R J Ocul Pharmacol Ther; 2012 Feb; 28(1):94-6. PubMed ID: 22103968 [TBL] [Abstract][Full Text] [Related]
2. Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study. Virtanen HM; Reitamo S; Kari M; Kari O Acta Ophthalmol Scand; 2006 Oct; 84(5):693-5. PubMed ID: 16965503 [TBL] [Abstract][Full Text] [Related]
3. Tacrolimus ointment 0.03% in the eye for treatment of giant papillary conjunctivitis. Kymionis GD; Goldman D; Ide T; Yoo SH Cornea; 2008 Feb; 27(2):228-9. PubMed ID: 18216583 [TBL] [Abstract][Full Text] [Related]
4. Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders. Joseph MA; Kaufman HE; Insler M Cornea; 2005 May; 24(4):417-20. PubMed ID: 15829797 [TBL] [Abstract][Full Text] [Related]
5. Topical tacrolimus ointment for treatment of intractable atopic keratoconjunctivitis: a case report and review of the literature. García DP; Alperte JI; Cristóbal JA; Mateo Orobia AJ; Muro EM; Valyi Z; Del Rio BJ; Arnao MR Cornea; 2011 Apr; 30(4):462-5. PubMed ID: 20861732 [TBL] [Abstract][Full Text] [Related]
6. Tacrolimus ointment in atopic blepharoconjunctivitis does not seem to elevate intraocular pressure. Remitz A; Virtanen HM; Reitamo S; Kari O Acta Ophthalmol; 2011 May; 89(3):e295-6. PubMed ID: 20064110 [No Abstract] [Full Text] [Related]
7. Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis. Al-Amri AM Am J Ophthalmol; 2014 Feb; 157(2):280-6. PubMed ID: 24439439 [TBL] [Abstract][Full Text] [Related]
14. Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis. Liu FY; Liu HY; Chu HS; Chen WL; Hu FR; Wang IJ Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):967-974. PubMed ID: 30852635 [TBL] [Abstract][Full Text] [Related]
15. Tacrolimus ointment 0.03% for treatment of refractory childhood phlyctenular keratoconjunctivitis. Kymionis GD; Kankariya VP; Kontadakis GA Cornea; 2012 Aug; 31(8):950-2. PubMed ID: 22525784 [TBL] [Abstract][Full Text] [Related]
16. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis. Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C; Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994 [TBL] [Abstract][Full Text] [Related]
17. Topical calcineurin inhibitors in the treatment of steroid-dependent atopic keratoconjunctivitis. Tzu JH; Utine CA; Stern ME; Akpek EK Cornea; 2012 Jun; 31(6):649-54. PubMed ID: 22378107 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis. Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874 [TBL] [Abstract][Full Text] [Related]
19. Atopic dermatitis management with tacrolimus ointment (Protopic). Kapp A; Allen BR; Reitamo S J Dermatolog Treat; 2003; 14(Suppl 1):5-16. PubMed ID: 14522634 [TBL] [Abstract][Full Text] [Related]
20. Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis. Nivenius E; van der Ploeg I; Jung K; Chryssanthou E; van Hage M; Montan PG Eye (Lond); 2007 Jul; 21(7):968-75. PubMed ID: 16680103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]